Dow Down0.32% Nasdaq Down0.62%

More On VRX.TO

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials


Valeant Pharmaceuticals International, Inc. (VRX.TO)

-Toronto
41.83 Down 2.41(5.45%) Apr 29
Analyst OpinionGet Analyst Opinion for:
Recommendation Summary*
Mean Recommendation (this week):2.8
Mean Recommendation (last week):2.7
Change:0.1

* (Strong Buy) 1.0 - 5.0 (Sell)

Price Target Summary
Mean Target:53.83
Median Target:55.00
High Target:66.00
Low Target:40.00
No. of Brokers:6

Data provided by Thomson/First Call

Upgrades & Downgrades History
No Upgrades & Downgrades available for VRX.TO

Recommendation Trends
Current MonthLast MonthTwo Months AgoThree Months Ago
Strong Buy1122
Buy1143
Hold7731
Underperform0000
Sell0000

Data provided by Thomson/First Call


Currency in CAD.